Zheng_2009_Bioorg.Med.Chem_17_4477

Reference

Title : QSAR study on maximal inhibition (Imax) of quaternary ammonium antagonists for S-(-)-nicotine-evoked dopamine release from dopaminergic nerve terminals in rat striatum - Zheng_2009_Bioorg.Med.Chem_17_4477
Author(s) : Zheng F , McConnell MJ , Zhan CG , Dwoskin LP , Crooks PA
Ref : Bioorganic & Medicinal Chemistry , 17 :4477 , 2009
Abstract :

Maximal inhibition (I(max)) of the agonist effect is an important pharmacological property of inhibitors that interact with multiple receptor subtypes that are activated by the same agonist and which elicit the same functional response. This report represents the first QSAR study on a set of 66 mono- and bis-quaternary ammonium salts that act as antagonists at neuronal nicotinic acetylcholine receptors mediating nicotine-evoked dopamine release, conducted using multi-linear regression (MLR) and neural network (NN) analysis with the maximal inhibition (I(max)) values of the antagonists as target values. The statistical results for the generated MLR model were: r(2)=0.89, rmsd=9.01, q(2)=0.83 and loormsd=11.1; the statistical results for the generated NN model were: r(2)=0.89, rmsd=8.98, q(2)=0.83 and loormsd=11.2. The maximal inhibition values of the compounds exhibited a good correlation with the predictions made by the QSAR models developed, which provide a basis for rationalizing selection of compounds for synthesis in the discovery of effective and selective second generation inhibitors of nAChRs mediating nicotine-evoked dopamine release.

PubMedSearch : Zheng_2009_Bioorg.Med.Chem_17_4477
PubMedID: 19477134

Related information

Citations formats

Zheng F, McConnell MJ, Zhan CG, Dwoskin LP, Crooks PA (2009)
QSAR study on maximal inhibition (Imax) of quaternary ammonium antagonists for S-(-)-nicotine-evoked dopamine release from dopaminergic nerve terminals in rat striatum
Bioorganic & Medicinal Chemistry 17 :4477

Zheng F, McConnell MJ, Zhan CG, Dwoskin LP, Crooks PA (2009)
Bioorganic & Medicinal Chemistry 17 :4477